CDXS— CODEXIS, INC.

MaterialsLife Sciences Tools & Services$136M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Total revenues	$70.4M+18.6%	$59.3M-15.4%	$70.1M-49.4%	$138.6M
Cost of product revenue	$9.3M-42.7%	$16.3M+27.2%	$12.8M-66.3%	$38.0M
Research and development	$52.3M+13.1%	$46.3M-21.4%	$58.9M-26.5%	$80.1M
Selling, general and administrative	$47.1M-14.6%	$55.1M+3.6%	$53.3M+2.1%	$52.2M
Restructuring charges	$3.4M	$0-100.0%	$3.3M+3.7%	$3.2M
Asset impairment and other charges	$0-100.0%	$165K-98.3%	$10.0M	$0
Total costs and operating expenses	$112.1M-4.9%	$117.9M-14.7%	$138.2M-20.3%	$173.5M
Loss from operations	-$41.7M+28.7%	-$58.5M+14.0%	-$68.1M-95.1%	-$34.9M
Interest income	$2.6M-28.5%	$3.7M-12.0%	$4.2M+189.5%	$1.4M
Interest and other expense, net	-$4.8M+53.7%	-$10.4M+15.3%	-$12.3M-9998.4%	$124K
Loss before income taxes	-$43.9M+32.7%	-$65.2M+14.3%	-$76.2M-128.6%	-$33.3M
Provision for income taxes	$47K+38.2%	$34K-50.7%	$69K-75.0%	$276K
Net loss	-$44.0M+32.6%	-$65.3M+14.4%	-$76.2M-127.0%	-$33.6M
Net loss per share, basic (in dollars per share)	-$500.00+43.8%	-$890.00+20.5%	-$1120.00-119.6%	-$510.00
Net loss per share, diluted (in dollars per share)	-$500.00+43.8%	-$890.00+20.5%	-$1120.00-119.6%	-$510.00
Weighted average common stock shares used in computing net loss per share, basic (in shares)	$87142000.00+18.7%	$73408000.00+7.7%	$68131000.00+4.3%	$65344000.00
Weighted average common stock shares used in computing net loss per share, diluted (in shares)	$87142000.00+18.7%	$73408000.00+7.7%	$68131000.00+4.3%	$65344000.00
Product revenue
Research and development revenue

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 11 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.